← Back to directory
CV
Convergent Ventures
San Francisco, CaliforniaWebsite ↗
Convergent Ventures is an early-stage venture capital firm that invests in science-driven health and sustainability technologies. The firm backs founders leveraging the convergence of data with natural, physical, and human sciences to create impactful solutions for human and planetary health.
Last raised
Jan 2021
5y 9mo ago
Latest fund size
$35M
Convergent Seed Fund
AUM
$35M
estimated
Funds raised
Capital this firm has raised, newest first
Small World Group
Unknown
—
Convergent Seed Fund
Jan 2021
$35M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Contraline | — | $92.5M | Jun 2026 | |
| Dandelion Health | Series A | $14M | May 2026 | |
| Profluent Bio | Series B | — | Nov 2025 | |
| Novamera | — | — | Nov 2025 | |
| Ubicept | Series A | — | Jun 2025 | |
| Tensor Bio | — | — | May 2025 | |
| FibreCoat | — | $21.5M | Dec 2024 | |
| NanoVation TherapeuticsLead | — | — | Dec 2024 |
Sources
Where this data came from